Schedule 13D ownership disclosure

NEOLEUKIN THERAPEUTICS INC

Security class unavailable · CUSIP: 64049K104

Event date: 2019-11-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,305,679
Percent of class
29.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-065138
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Nov 18, 2019
Reporting period
Nov 12, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub